141 related articles for article (PubMed ID: 9758659)
81. Transient expression technologies: past, present, and future.
Geisse S; Voedisch B
Methods Mol Biol; 2012; 899():203-19. PubMed ID: 22735955
[TBL] [Abstract][Full Text] [Related]
82. Cultural and physiological factors affecting expression of recombinant proteins.
Griffiths JB; Racher AJ
Cytotechnology; 1994; 15(1-3):3-9. PubMed ID: 7765943
[TBL] [Abstract][Full Text] [Related]
83. Identifying and engineering promoters for high level and sustainable therapeutic recombinant protein production in cultured mammalian cells.
Ho SC; Yang Y
Biotechnol Lett; 2014 Aug; 36(8):1569-79. PubMed ID: 24737078
[TBL] [Abstract][Full Text] [Related]
84. Changes in cell adhesion and cell proliferation are associated with expression of tissue non-specific alkaline phosphatase.
Hui M; Hu M; Tenenbaum HC
Cell Tissue Res; 1993 Dec; 274(3):429-37. PubMed ID: 7507406
[TBL] [Abstract][Full Text] [Related]
85. Analysis of foreign protein overproduction in recombinant CHO cells. Effect of growth kinetics and cell cycle traverse.
Gu MB; Todd P; Kompala DS
Ann N Y Acad Sci; 1994 May; 721():194-207. PubMed ID: 8010670
[TBL] [Abstract][Full Text] [Related]
86. Mammalian cell cultures. Part III: Safety and future aspects.
Werner RG; Noé W
Arzneimittelforschung; 1993 Dec; 43(12):1388-90. PubMed ID: 8141832
[TBL] [Abstract][Full Text] [Related]
87. Recent advances in inducible gene expression systems.
Rossi FM; Blau HM
Curr Opin Biotechnol; 1998 Oct; 9(5):451-6. PubMed ID: 9821271
[TBL] [Abstract][Full Text] [Related]
88. Nomenclature and guideline to express the amount of a membrane protein synthesized in animal cells in view of bioprocess optimization and production monitoring.
Augusto EF; Moraes AM; Piccoli RA; Barral MF; Suazo CA; Tonso A; Pereira CA
Biologicals; 2010 Jan; 38(1):105-12. PubMed ID: 19699109
[TBL] [Abstract][Full Text] [Related]
89. Recombinant glycoprotein product quality in proliferation-controlled BHK-21 cells.
Mueller PP; Schlenke P; Nimtz M; Conradt HS; Hauser H
Biotechnol Bioeng; 1999 Dec; 65(5):529-36. PubMed ID: 10516578
[TBL] [Abstract][Full Text] [Related]
90. Identification of mammalian cell clones exhibiting highly regulated expression from inducible promoters.
Kirchhoff S; Köster M; Wirth M; Schaper F; Gossen M; Bujard H; Hauser H
Trends Genet; 1995 Jun; 11(6):219-20. PubMed ID: 7638903
[No Abstract] [Full Text] [Related]
91. A possible function of DNA curvature in a vector system that allows efficient expression of heterologous proteins in CHO cells.
Hirota Y; Maeda T; Yan H; Nakamichi N; Matsumura T
Nucleic Acids Symp Ser; 1999; (42):87-8. PubMed ID: 10780392
[TBL] [Abstract][Full Text] [Related]
92. Cell line development for continuous high cell density biomanufacturing: Exploiting hypoxia for improved productivity.
Zeh N; Schlossbauer P; Raab N; Klingler F; Handrick R; Otte K
Metab Eng Commun; 2021 Dec; 13():e00181. PubMed ID: 34401326
[TBL] [Abstract][Full Text] [Related]
93. Efficient and inducible production of human interleukin 6 in Chinese hamster ovary cells using a novel expression system.
Zhang Y; Katakura Y; Ohashi H; Shirahata S
Cytotechnology; 1997 Nov; 25(1-3):53-60. PubMed ID: 22358879
[TBL] [Abstract][Full Text] [Related]
94. Optimization of extended Kozak elements enhances recombinant proteins expression in CHO cells.
Li ZM; Lin Y; Luo CH; Sun QL; Mi CL; Wang XY; Wang TY
J Biotechnol; 2024 Jul; 392():96-102. PubMed ID: 38960098
[TBL] [Abstract][Full Text] [Related]
95. Decoupling Growth and Protein Production in CHO Cells: A Targeted Approach.
Donaldson JS; Dale MP; Rosser SJ
Front Bioeng Biotechnol; 2021; 9():658325. PubMed ID: 34150726
[TBL] [Abstract][Full Text] [Related]
96. Proliferation control strategies to improve productivity and survival during CHO based production culture : A summary of recent methods employed and the effects of proliferation control in product secreting CHO cell lines.
Kumar N; Gammell P; Clynes M
Cytotechnology; 2007 Apr; 53(1-3):33-46. PubMed ID: 19003188
[TBL] [Abstract][Full Text] [Related]
97. The effects of cell adhesion on the growth and protein productivity of animal cells.
Nishijima K; Fujiki T; Kojima H; Iijima S
Cytotechnology; 2000 Jul; 33(1-3):147-55. PubMed ID: 19002822
[TBL] [Abstract][Full Text] [Related]
98. A regulatable selective system facilitates isolation of heterologous protein hyper-producing mammalian cells without gene amplification.
Teruya K; Zhang Y; Katakura Y; Shirahata S
Cytotechnology; 2002 Nov; 40(1-3):13-22. PubMed ID: 19003100
[TBL] [Abstract][Full Text] [Related]
99. Application of a reversible immortalization system for the generation of proliferation-controlled cell lines.
May T; Lindenmaier W; Wirth D; Mueller PP
Cytotechnology; 2004 Oct; 46(2-3):69-78. PubMed ID: 19003263
[TBL] [Abstract][Full Text] [Related]
100. From Efficiency to Yield: Exploring Recent Advances in CHO Cell Line Development for Monoclonal Antibodies.
Majumdar S; Desai R; Hans A; Dandekar P; Jain R
Mol Biotechnol; 2024 Feb; ():. PubMed ID: 38363529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
